Composition comprising live-attenuated tetravalent dengue virus
TW202641967APending Publication Date: 2026-10-16KM BIOLOGICS CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114150856
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-24
- Filing Date
- 2025-12-23
- Publication Date
- 2026-10-16
Smart Images
Figure 00000000_0000_ABST
Abstract
The present invention relates to a stabilized formulation for a live-attenuated tetravalent dengue virus vaccine (lyophilized preparation), necessitating the identification of the optimal composition. The present invention provides a lyophilized composition comprising live-attenuated tetravalent dengue virus, wherein the composition comprises D-sorbitol, glycine, and trehalose hydrate.
Need to check novelty before this filing date? Find Prior Art